WS15.02 Real-world effectiveness of elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) in people with cystic fibrosis and ELX/TEZ/IVA-responsive, non-F508del CFTR genotypes.

Autor:	Mahic, M.1 (AUTHOR), Liu, L.1 (AUTHOR), Jennings, M.1 (AUTHOR), Rice, M.1 (AUTHOR)
Zdroj:	Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS28-S28. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect